Top managers at troubled crypto brokerage firm Genesis had privileged early access to new tokens planned for listing on the now-bankrupt crypto exchange FTX, the Financial Times has learned.
Subscribe to our Telegram channel to get daily short digests about events that shape the crypto world
People familiar with the matter told the media that Genesis executives could invest in tokens at a discounted rate before they were listed on the exchange. One of Genesis former executives confirmed privately that the firm's top managers bought SRM tokens, which later spiked 1,500%.
These offerings have been made in response to funding Alameda Research, Bankman-Fried's private hedge fund, the report notes. The Financial Times notes it is unclear how widespread this scheme was within Genesis.
FTX, through subsidiaries, invested about $5.3 billion in 475 deals. The amounts ranged from $100 million for Mysten Labs to $1 million in checks for Limit Break or Messari. FTX also transferred $2.2 billion to its founder Sam Bankman-Fried through different entities, including Alameda.
Access more than 50 of the world's financial markets directly from your EXANTE account – including NASDAQ, London Stock Exchange and Tokyo Stock Exchange